BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 29937235)

  • 1. Liver reirradiation for patients with hepatocellular carcinoma and liver metastasis.
    McDuff SGR; Remillard KA; Zheng H; Raldow AC; Wo JY; Eyler CE; Drapek LC; Goyal L; Blaszkowsky LS; Clark JW; Allen JN; Parikh AR; Ryan DP; Ferrone CR; Tanabe KK; Wolfgang JA; Zhu AX; Hong TS
    Pract Radiat Oncol; 2018; 8(6):414-421. PubMed ID: 29937235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical parameters for predicting radiation-induced liver disease after intrahepatic reirradiation for hepatocellular carcinoma.
    Huang Y; Chen SW; Fan CC; Ting LL; Kuo CC; Chiou JF
    Radiat Oncol; 2016 Jul; 11(1):89. PubMed ID: 27369241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensity modulated radiation therapy with pulsed reduced dose rate as a reirradiation strategy for recurrent central nervous system tumors: An institutional series and literature review.
    Murphy ES; Rogacki K; Godley A; Qi P; Reddy CA; Ahluwalia MS; Peereboom DM; Stevens GH; Yu JS; Kotecha R; Suh JH; Chao ST
    Pract Radiat Oncol; 2017; 7(6):e391-e399. PubMed ID: 28666902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric Factors and Toxicity in Highly Conformal Thoracic Reirradiation.
    Binkley MS; Hiniker SM; Chaudhuri A; Maxim PG; Diehn M; Loo BW; Shultz DB
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):808-15. PubMed ID: 26831903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Definitive reirradiation for locoregionally recurrent non-small cell lung cancer with proton beam therapy or intensity modulated radiation therapy: predictors of high-grade toxicity and survival outcomes.
    McAvoy S; Ciura K; Wei C; Rineer J; Liao Z; Chang JY; Palmer MB; Cox JD; Komaki R; Gomez DR
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):819-27. PubMed ID: 25220718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-Institutional Prospective Study of Reirradiation with Proton Beam Radiotherapy for Locoregionally Recurrent Non-Small Cell Lung Cancer.
    Chao HH; Berman AT; Simone CB; Ciunci C; Gabriel P; Lin H; Both S; Langer C; Lelionis K; Rengan R; Hahn SM; Prabhu K; Fagundes M; Hartsell W; Mick R; Plastaras JP
    J Thorac Oncol; 2017 Feb; 12(2):281-292. PubMed ID: 27826034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reirradiation for recurrent primary central nervous system tumors: Eight-year audit from a tertiary cancer care center in South India.
    Menon D; Chelakkot PG
    Indian J Cancer; 2017; 54(2):409-414. PubMed ID: 29469068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reirradiation with concurrent bevacizumab for recurrent high-grade gliomas in adult patients.
    Schernberg A; Dhermain F; Ammari S; Dumont SN; Domont J; Patrikidou A; Pallud J; Dezamis É; Deutsch É; Louvel G
    Cancer Radiother; 2018 Feb; 22(1):9-16. PubMed ID: 29217134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Multi-Institutional Retrospective Study of Repeated Stereotactic Body Radiation Therapy for Intrahepatic Recurrent Hepatocellular Carcinoma.
    Kimura T; Takeda A; Tsurugai Y; Kawano R; Doi Y; Oku Y; Hioki K; Miura H; Nagata Y
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1265-1275. PubMed ID: 32712256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Prospective Study of Proton Beam Reirradiation for Esophageal Cancer.
    Fernandes A; Berman AT; Mick R; Both S; Lelionis K; Lukens JN; Ben-Josef E; Metz JM; Plastaras JP
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):483-487. PubMed ID: 26847847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbon ion reirradiation compared to intensity-modulated re-radiotherapy for recurrent head and neck cancer (CARE): a randomized controlled trial.
    Held T; Lang K; Regnery S; Weusthof K; Hommertgen A; Jäkel C; Tonndorf-Martini E; Krisam J; Plinkert P; Zaoui K; Freudlsperger C; Moratin J; Krauss J; Harrabi SB; Herfarth K; Debus J; Adeberg S
    Radiat Oncol; 2020 Aug; 15(1):190. PubMed ID: 32758267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperfractionated abdominal reirradiation for gastrointestinal malignancies.
    Hunt A; Das P; Minsky BD; Koay EJ; Krishnan S; Herman JM; Taniguchi C; Koong A; Smith GL; Holliday EB
    Radiat Oncol; 2018 Aug; 13(1):143. PubMed ID: 30086784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reirradiation of Recurrent and Second Primary Head and Neck Cancer With Proton Therapy.
    McDonald MW; Zolali-Meybodi O; Lehnert SJ; Estabrook NC; Liu Y; Cohen-Gadol AA; Moore MG
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(4):808-819. PubMed ID: 27788954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensity-Modulated Radiotherapy-Based Reirradiation for Head and Neck Cancer: A Multi-institutional Study by Korean Radiation Oncology Group (KROG 1707).
    Lee J; Kim TH; Kim YS; Kim M; Park JW; Kim SH; Kim HJ; Lee CG
    Cancer Res Treat; 2020 Oct; 52(4):1031-1040. PubMed ID: 32632081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes after reirradiation of spinal metastasis with stereotactic body radiation therapy (SBRT): a retrospective single institutional study.
    Sasamura K; Suzuki R; Kozuka T; Yoshimura R; Yoshioka Y; Oguchi M
    J Radiat Res; 2020 Nov; 61(6):929-934. PubMed ID: 32766715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reirradiation for locally recurrent lung cancer previously treated with radiation therapy.
    Okamoto Y; Murakami M; Yoden E; Sasaki R; Okuno Y; Nakajima T; Kuroda Y
    Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):390-6. PubMed ID: 11872284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges in Reirradiation of Intrahepatic Tumors.
    Owen D; Lukovic J; Hosni A; Crane CH; Hong TS; Dawson LA; Velec M; Lawrence TS
    Semin Radiat Oncol; 2020 Jul; 30(3):242-252. PubMed ID: 32503790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal stereotactic body radiotherapy dosage for hepatocellular carcinoma: a multicenter study.
    Su TS; Liu QH; Zhu XF; Liang P; Liang SX; Lai L; Zhou Y; Huang Y; Cheng T; Li LQ
    Radiat Oncol; 2021 Apr; 16(1):79. PubMed ID: 33882972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and toxicity of helical tomotherapy for patients with locally recurrent nasopharyngeal carcinoma.
    Puebla F; Lopez Guerra JL; Garcia Ramirez JM; Matute R; Marrone I; Miguez C; Sevillano D; Sanchez-Reyes A; Rivin Del Campo E; Praena-Fernandez JM; Azinovic I
    Clin Transl Oncol; 2015 Nov; 17(11):925-31. PubMed ID: 26108408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.